Barclays PLC Moderna, Inc. Put Options Transaction History

Barclays PLC

12 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 15, 2024	BUY	$63.64 - $125.14 $1.27 Million - $2.5 Million	20,000 New	20,000 $1.34 Million
Q1 2024 May 15, 2024	BUY	$85.37 - $115.44 $1.71 Million - $2.31 Million	20,000 New	20,000 $2.13 Million
Q1 2023 May 04, 2023	SELL	$135.66 - $197.02 $15.1 Million - $21.9 Million	-111,400 Reduced 20.77%	424,900 $65.3 Million
Q4 2022 Feb 13, 2023	BUY	$118.38 - $210.04 $63.5 Million - $113 Million	536,300 New	536,300 $96.3 Million
Q2 2022 Aug 12, 2022	SELL	$117.13 - $176.59 $221 Million - $334 Million	-1,889,200 Reduced 79.88%	475,700 $68 Million
Q4 2021 Feb 14, 2022	BUY	$225.82 - $368.51 $514 Million - $839 Million	2,276,600 Added 2578.26%	2,364,900 $601 Million
Q3 2021 Nov 09, 2021	BUY	$221.9 - $484.47 $6.68 Million - $14.6 Million	30,100 Added 51.72%	88,300 $34 Million
Q2 2021 Aug 13, 2021	BUY	$129.91 - $234.98 $1.07 Million - $1.93 Million	8,200 Added 16.4%	58,200 $13.7 Million
Q1 2021 May 13, 2021	SELL	$109.18 - $185.98 $9.35 Million - $15.9 Million	-85,600 Reduced 63.13%	50,000 $6.55 Million
Q4 2020 Feb 11, 2021	SELL	$65.74 - $169.86 $3.02 Million - $7.8 Million	-45,900 Reduced 25.29%	135,600 $14.2 Million
Q3 2020 Nov 12, 2020	BUY	$54.34 - $94.85 $9.05 Million - $15.8 Million	166,500 Added 1110.0%	181,500 $12.8 Million
Q2 2020 Aug 12, 2020	BUY	$29.67 - $80.0 $445,050 - $1.2 Million	15,000 New	15,000 $963,000

953

240M

10.6M

18.7M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $15.8B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

Stay updated on Barclays PLC with notifications on news.